Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Revenue
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	2,335,499	1,655,734
Depreciation	1,744	1,981
Research and development (including stock-based compensation (Note 8))	1,185,317	425,983
Total operating expenses	3,522,560	2,083,698
Loss from operations	(3,522,560)	(2,083,698)
Other (income) expense:
Gain on extinguishment of liabilities (Notes 5 and 9)	(875,852)
Conversion inducement	10,784
Interest expense	360,492	379,189
Total other (income) expense	(504,576)	379,189
Net loss	(3,017,984)	(2,462,887)
Net loss attributable to the noncontrolling interest	2,994	2,414
Net loss applicable to Bion's common stockholders	$ (3,014,990)	$ (2,460,473)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.12)	$ (0.10)
Weighted-average number of common shares outstanding:
Basic and diluted (in shares)	24,439,059	23,459,931